Loading resource…

Ingrid E. Lundberg, Manabu Fujimoto, Jiri Vencovsky, Rohit Aggarwal, Marie Holmqvist, Lisa Christopher-Stine, Andrew L. Mammen, Frederick W. Miller
Idiopathic inflammatory myopathies (IIM) are systemic inflammatory disorders that present with muscle weakness and can affect various organs, including the skin, joints, and lungs. The document classifies IIM into several subgroups based on clinical, histopathological, and serological features, such as dermatomyositis and polymyositis. It emphasizes the importance of understanding the molecular pathways and auto-antigens involved in these disorders to improve patient outcomes and guide treatment decisions. The document also highlights the need for targeted therapies and biomarkers for better management of IIM.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial
Same clinical topic · Rheumatology

EARLY TRAUMA AS THE ORIGIN OF CHRONIC INFLAMMATION: A PSYCHONEUROIMMUNOLOGICAL PERSPECTIVE
Same clinical topic · Rheumatology

MULTIFACTORIAL PATHOGENESIS OF RHEUMATOID ARTHRITIS
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS IN CRITICAL CARE: A SYSTEMATIC REVIEW OF ICU OUTCOMES AND MANAGEMENT
Same clinical topic · Rheumatology

RHEUMATOID ARTHRITIS — COMMON ORIGINS, DIVERGENT MECHANISMS
Same clinical topic · Rheumatology

RHEUMATOID ARTHRITIS IN ADULTS
Same clinical topic · Rheumatology

BIOLOGICAL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS AND TREATMENT
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS: NEW DIAGNOSTIC AND THERAPEUTIC APPROACHES
Same clinical topic · Rheumatology